Rallybio Declares $13.56/Share Special Cash Distribution Tied to Avenzo Merger

summarizeSummary

Rallybio declared an estimated $82.7 million ($13.56 per share) special cash distribution payable to holders of record November 5, conditioned on shareholder approval of the Avenzo merger at the November 4 vote.

check_boxKey Events · M&A and Partnerships · RLYB

• Special Cash Distribution Declared

  Board declared an estimated $82.7 million aggregate distribution, or approximately $13.56 per share, to stockholders and pre-funded warrant holders of record as of November 5, 2026.

• Payout Conditioned on Merger Vote

  Payment requires the Required Company Stockholder Vote at the November 4, 2026 annual meeting; merger closing is expected on or about November 6, 2026.

• Due Bill and Ex-Dividend Mechanics

  Because the distribution exceeds 25% of the stock price on the declaration date, Nasdaq is expected to set a November 6, 2026 ex-dividend date, with a due bill period from November 4 through November 6 — holders must own through November 6 to receive the cash.

• CVR Record Date Fixed

  The board set the same November 5 record date for the previously announced contingent value rights distribution tied to the merger.

auto_awesomeAnalysis · RLYB · Life Sciences

Rallybio's board has put a hard number on the cash shareholders will receive when the Avenzo reverse merger closes: an estimated $82.7 million, or about $13.56 per share, against a $16.65 stock price. Most of today's share value, in other words, is the cash being returned, with the remainder pricing the Avenzo business and the contingent value rights. The payout is not automatic — it requires shareholder approval at the November 4 meeting, with closing expected around November 6. For anyone trading around the record date, the due bill mechanics matter: buyers must hold through November 6 to receive the distribution.